Bluebird Bio Stock Probability of Future Stock Price Finishing Over 0.97
| BLUE Stock | USD 0.97 0.02 2.11% |
Closest to current price Bluebird long CALL Option Payoff at Expiration
Bluebird |
Bluebird Bio Target Price Odds to finish over 0.97
The tendency of Bluebird Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.97 | 90 days | 0.97 | about 89.44 |
Based on a normal probability distribution, the odds of Bluebird Bio to move above the current price in 90 days from now is about 89.44 (This Bluebird bio probability density function shows the probability of Bluebird Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 3.88 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Bluebird Bio will likely underperform. Additionally Bluebird bio has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Bluebird Bio Price Density |
| Price |
Predictive Modules for Bluebird Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bluebird bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bluebird Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bluebird Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bluebird Bio is not an exception. The market had few large corrections towards the Bluebird Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bluebird bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bluebird Bio within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -0.65 | |
β | Beta against NYSE Composite | 3.88 | |
σ | Overall volatility | 0.20 | |
Ir | Information ratio | -0.06 |
Bluebird Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bluebird Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bluebird bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bluebird bio had very high historical volatility over the last 90 days | |
| Bluebird bio has some characteristics of a very speculative penny stock | |
| Bluebird bio has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 21.73 M. Net Loss for the year was (91.17 M) with loss before overhead, payroll, taxes, and interest of (247.24 M). | |
| Bluebird bio currently holds about 132.51 M in cash with (277.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Bluebird bio has a frail financial position based on the latest SEC disclosures | |
| Roughly 65.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from accesswire.com: Levi Korsinsky Reminds bluebird bio Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 28, 2024 - BLUE |
Bluebird Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bluebird Stock often depends not only on the future outlook of the current and potential Bluebird Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bluebird Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 78.6 M | |
| Cash And Short Term Investments | 181.7 M |
Bluebird Bio Technical Analysis
Bluebird Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Bluebird Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Bluebird bio. In general, you should focus on analyzing Bluebird Stock price patterns and their correlations with different microeconomic environments and drivers.
Bluebird Bio Predictive Forecast Models
Bluebird Bio's time-series forecasting models is one of many Bluebird Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Bluebird Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Bluebird bio
Checking the ongoing alerts about Bluebird Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Bluebird bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Bluebird bio had very high historical volatility over the last 90 days | |
| Bluebird bio has some characteristics of a very speculative penny stock | |
| Bluebird bio has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 21.73 M. Net Loss for the year was (91.17 M) with loss before overhead, payroll, taxes, and interest of (247.24 M). | |
| Bluebird bio currently holds about 132.51 M in cash with (277.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Bluebird bio has a frail financial position based on the latest SEC disclosures | |
| Roughly 65.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from accesswire.com: Levi Korsinsky Reminds bluebird bio Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 28, 2024 - BLUE |
Check out Bluebird Bio Backtesting, Bluebird Bio Valuation, Bluebird Bio Correlation, Bluebird Bio Hype Analysis, Bluebird Bio Volatility, Bluebird Bio History as well as Bluebird Bio Performance. For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Bluebird Stock analysis
When running Bluebird Bio's price analysis, check to measure Bluebird Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluebird Bio is operating at the current time. Most of Bluebird Bio's value examination focuses on studying past and present price action to predict the probability of Bluebird Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluebird Bio's price. Additionally, you may evaluate how the addition of Bluebird Bio to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |
Is Bluebird Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluebird Bio. If investors know Bluebird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluebird Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.63) | Revenue Per Share 0.214 | Quarterly Revenue Growth 173.535 | Return On Assets (0.15) | Return On Equity (0.48) |
The market value of Bluebird bio is measured differently than its book value, which is the value of Bluebird that is recorded on the company's balance sheet. Investors also form their own opinion of Bluebird Bio's value that differs from its market value or its book value, called intrinsic value, which is Bluebird Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluebird Bio's market value can be influenced by many factors that don't directly affect Bluebird Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bluebird Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluebird Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluebird Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.